This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Case Western Reserve University, Oregon Health & Science University, The University of Hong Kong. Active years: 2018-2024.
Company Filing History:
8 out of 1,364 
2 out of 524 
1 out of 374 
Years Active: 2018-2024
Title: The Innovations of Bradley T Lang
Introduction
Bradley T Lang is an inventor based in the United States, known for his contributions to the field of therapeutic agents. His work focuses on developing methods to inhibit the activity of LAR family phosphatases, which play a significant role in various neurological conditions.
Latest Patents
Bradley T Lang holds a patent titled "Compositions And Methods For Inhibiting The Activity Of Lar Family Phosphatases." This patent discloses a therapeutic agent and a pharmaceutical composition that inhibit or reduce the catalytic activity, signaling, and function of LAR family phosphatases in cells. The therapeutic agent is particularly relevant for treating neurological injuries or disorders.
Career Highlights
Throughout his career, Lang has made significant strides in the development of pharmaceutical compositions aimed at addressing critical health issues. His innovative approach to targeting specific phosphatases has the potential to lead to breakthroughs in treatment methodologies.
Collaborations
Lang has collaborated with notable colleagues, including Jared M Cregg and Jerry Silver, who have contributed to his research endeavors. Their combined expertise has enhanced the development of therapeutic strategies in the field.
Conclusion
Bradley T Lang's work exemplifies the importance of innovation in the medical field, particularly in developing treatments for neurological disorders. His contributions continue to pave the way for future advancements in therapeutic agents.